BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $666,550 | +167.2% | 131,990 | 0.0% | 0.03% | +188.9% |
| Q1 2023 | $249,461 | +5.0% | 131,990 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $237,582 | +6.5% | 131,990 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $223,000 | -31.4% | 131,990 | 0.0% | 0.01% | -30.8% |
| Q2 2022 | $325,000 | -11.2% | 131,990 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $366,000 | -48.0% | 131,990 | 0.0% | 0.01% | -43.5% |
| Q4 2021 | $704,000 | -37.0% | 131,990 | 0.0% | 0.02% | -36.1% |
| Q3 2021 | $1,117,000 | -30.6% | 131,990 | 0.0% | 0.04% | -30.8% |
| Q2 2021 | $1,609,000 | -49.8% | 131,990 | 0.0% | 0.05% | -52.7% |
| Q1 2021 | $3,202,000 | – | 131,990 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |